MRI ‘Probe’ Noninvasively Measures Placental Health
By MedImaging International staff writers Posted on 08 Feb 2024 |
The health of the placenta is essential for the well-being of a baby. However, currently, there isn't a direct method to evaluate how effectively this vital organ functions. Researchers have now demonstrated a noninvasive technique that has the potential to assess placental health during pregnancy. They achieved this by using advanced MRI methods to measure placental vascular reactivity, which refers to the placenta's ability to adjust its blood supply according to the fetus's needs.
In their study, researchers at Children’s Hospital Los Angeles (Los Angeles, CA, USA) focused on the placenta's crucial role in maintaining a stable oxygen environment for the developing fetus. The study involved 34 women with healthy pregnancies, whose gestational ages ranged from 22 to 32 weeks. Each participant underwent a seven-minute placental MRI examination. During the MRI, the women were instructed via video to perform yoga-like breathing exercises, including inhaling, holding their breath briefly, and then exhaling slowly. The researchers monitored the changing carbon dioxide levels of the mothers during these exercises. Employing a technique known as blood oxygen-dependent MRI, they observed the dilation and contraction of the placenta’s vascular system in response to these changing levels, without the use of external oxygen or contrast agents. The researchers aimed to assess the placenta's response to everyday changes and situations, rather than creating an artificial environment.
The findings of the study indicate that MRI can reliably measure placental vascular reactivity using these methods. This proof-of-concept study introduces a novel, noninvasive way to assess placental vascular health and function during pregnancy. The researchers also discovered that the placenta becomes more responsive as the fetus matures. Furthermore, they noted that irrespective of gestational age, a more reactive placenta correlated with a larger brain size in the baby. The research team’s next objective is to investigate the impact of placental dysfunction on brain development in babies with congenital heart disease. The ultimate aim is to enable clinicians to use placental vascular reactivity as a diagnostic tool for early detection of placental dysfunction, allowing for timely intervention.
“It’s exciting because this could serve as a potential biomarker, or functional probe, of placental health,” said Vidya Rajagopalan, Ph.D., an investigator in the Division of Cardiology at CHLA. “And it’s noninvasive. It doesn’t hurt mom; it doesn’t hurt baby.”
Related Links:
Children’s Hospital Los Angeles
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer